Treatment Policy rather than Patient Characteristics Determines Convection Volume in Online Post-Dilution Hemodiafiltration

被引:30
作者
Chapdelaine, Isabelle [1 ]
Mostovaya, Ira M. [2 ]
Blankestijn, Peter J. [2 ]
Bots, Michiel L. [3 ]
van den Dorpel, Marinus A. [4 ]
Levesque, Renee [5 ]
Nube, Menso J. [1 ,6 ]
ter Wee, Piet M. [1 ,6 ]
Grooteman, Muriel P. C. [1 ,6 ]
机构
[1] Vrije Univ Amsterdam Med Ctr, Dept Nephrol, Amsterdam, Netherlands
[2] Univ Med Ctr Utrecht, Dept Nephrol, Utrecht, Netherlands
[3] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
[4] Maasstad Hosp, Dept Internal Med, Rotterdam, Netherlands
[5] St Luc Hosp, Ctr Hosp Univ Montreal, Dept Nephrol, Montreal, PQ, Canada
[6] Vrije Univ Amsterdam Med Ctr, Inst Cardiovasc Res VU Med Ctr ICaR VU, Amsterdam, Netherlands
关键词
Dialysis; Hemodiafiltration; Convection volume; Vascular access; Filtration fraction; Dialyzer; PATIENTS RECEIVING HEMODIAFILTRATION; ALL-CAUSE MORTALITY; INTRADIALYTIC HYPOTENSION; CHRONIC-HEMODIALYSIS; RISK; EFFICIENCY; SURVIVAL; FLUX;
D O I
10.1159/000362108
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Background/Aims: Sub-analyses of three large trials showed that hemodiafiltration (HDF) patients who achieved the highest convection volumes had the lowest mortality risk. The aims of this study were (1) to identify determinants of convection volume and (2) to assess whether differences exist between patients achieving high and low volumes. Methods: HDF patients from the CONvective TRAnsport STudy (CONTRAST) with a complete dataset at 6 months (314 out of a total of 358) were included in this post hoc analysis. Determinants of convection volume were identified by regression analysis. Results: Treatment time, blood flow rate, dialysis vintage, serum albumin and hematocrit were independently related. Neither vascular access nor dialyzer characteristics showed any relation with convection volume. Except for some variation in body size, patient characteristics did not differ across tertiles of convection volume. Conclusion: Treatment time and blood flow rate are major determinants of convection volume. Hence, its magnitude depends on center policy rather than individualized patient prescription. (C) 2014 S. Karger AG, Basel
引用
收藏
页码:229 / 237
页数:9
相关论文
共 30 条
[1]
Clinical application of Ultracontrol®: infusion volume and use with different dialyzers [J].
Albalate Ramon, M. ;
Perez Garcia, R. ;
de Sequera Ortiz, P. ;
Alcazar Arroyo, R. ;
Corchete Prats, E. ;
Puerta Carretero, M. ;
Ortega Diaz, M. ;
Mosse, A. .
NEFROLOGIA, 2011, 31 (06) :683-689
[2]
Derivation and validation of a disease-specific risk score for cardiac risk stratification in chronic kidney disease [J].
Armstrong, KA ;
Rakhit, DJ ;
Case, C ;
Johnson, DW ;
Isbel, NM ;
Marwick, TH .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (10) :2097-2104
[3]
Hemodiafiltration: clinical evidence and remaining questions [J].
Blankestijn, Peter J. ;
Ledebo, Ingrid ;
Canaud, Bernard .
KIDNEY INTERNATIONAL, 2010, 77 (07) :581-587
[4]
Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS [J].
Canaud, B. ;
Bragg-Gresham, J. L. ;
Marshall, M. R. ;
Desmeules, S. ;
Gillespie, B. W. ;
Depner, T. ;
Klassen, P. ;
Port, F. K. .
KIDNEY INTERNATIONAL, 2006, 69 (11) :2087-2093
[5]
Serum β-2 microglobulin levels predict mortality in dialysis patients:: Results of the HEMO study [J].
Cheung, Alfred K. ;
Rocco, Michael V. ;
Yan, Guofen ;
Leypoldt, John K. ;
Levin, Nathan W. ;
Greene, Tom ;
Agodoa, Lawrence ;
Bailey, James ;
Beck, Gerald J. ;
Clark, William ;
Levey, Andrew S. ;
Ornt, Daniel B. ;
Schulman, Gerald ;
Schwab, Steven ;
Teehan, Brendan ;
Eknoyan, Garabed .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (02) :546-555
[6]
Conversion between bromcresol green- and bromcresol purple-measured albumin in renal disease [J].
Clase, CM ;
St Pierre, MW ;
Churchill, DN .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (09) :1925-1929
[7]
Collins AJ, 2010, AM J KIDNEY DIS, V55, pA426, DOI DOI 10.1053/J.AJKD.2009.10.009
[8]
Dialysis time, survival, and dose-targeting bias [J].
Daugirdas, John T. .
KIDNEY INTERNATIONAL, 2013, 83 (01) :9-13
[9]
Beta2-Microglobulin [J].
Drueke, Tilman B. ;
Massy, Ziad A. .
SEMINARS IN DIALYSIS, 2009, 22 (04) :378-380
[10]
Effect of dialysis dose and membrane flux in maintenance hemodialysis. [J].
Eknoyan, G ;
Beck, GJ ;
Cheung, AK ;
Daugirdas, JT ;
Greene, T ;
Kusek, JW ;
Allon, M ;
Bailey, J ;
Delmez, JA ;
Depner, TA ;
Dwyer, JT ;
Levey, AS ;
Levin, NW ;
Milford, E ;
Ornt, DB ;
Rocco, MV ;
Schulman, G ;
Schwab, SJ ;
Teehan, BP ;
Toto, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (25) :2010-2019